Tourmaline Bio Inc. (TRML) — Cash Flow Reinvestment Rate
Latest as of December 2023:
8.02x
Tourmaline Bio Inc. (TRML) has a Cash Flow Reinvestment Rate of 8.02x as of December 2023, reinvesting $88.42 Million (capex $2.00 plus investments $-88.42 Million) from operating cash flow of $11.02 Million. Check Tourmaline Bio Inc. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
8.02x
(Capex + Investments) / Operating CF
Total Reinvested
$88.42 Million
Capex + Investments
Operating Cash Flow
$11.02 Million
USD
Capital Expenditures
$2.00
USD
Annual Cash Flow Reinvestment Rate for Tourmaline Bio Inc. (None–None)
Year-by-year capital reinvestment analysis for Tourmaline Bio Inc.. For live market cap and broader valuation context, see TRML market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow